Overview

Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Ischemic Ventricular Tachyarrhythmias

Status:
Unknown status
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
The study evaluates whether catheter based radiofrequency ablation is superior to optimized antiarrhythmic medical therapy in preventing ventricular tachyarrhythmia relapses in patients with ischemic heart disease and implantable cardioverter defibrillator.
Phase:
Phase 4
Details
Lead Sponsor:
Central Finland Hospital District
Collaborator:
Biosense Webster, Inc.
Treatments:
Amiodarone
Anti-Arrhythmia Agents
Sotalol